Ensign Peak Advisors, Inc Argenx Se Transaction History

Ensign Peak Advisors, Inc

$56.1 Billion
Q3 2024

A detailed history of Ensign Peak Advisors, Inc transactions in Argenx Se stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 41,704 shares of ARGX stock, worth $26.6 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

41,704

Previous 42,207 1.19%

Holding current value

$26.6 Million

Previous $18.2 Million 24.61%

% of portfolio

0.04%

Previous 0.03%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$434.22 - $551.9 $218,412 - $277,605	-503 Reduced 1.19%	41,704 $22.6 Million
Q2 2024 Aug 13, 2024	SELL	$356.01 - $451.55 $1.32 Million - $1.67 Million	-3,702 Reduced 8.06%	42,207 $18.2 Million
Q1 2024 May 14, 2024	BUY	$356.95 - $413.29 $7.84 Million - $9.08 Million	21,970 Added 91.77%	45,909 $18.1 Million
Q4 2023 Feb 14, 2024	BUY	$338.91 - $506.01 $118,618 - $177,103	350 Added 1.48%	23,939 $9.11 Million
Q3 2023 Nov 13, 2023	SELL	$369.35 - $548.43 $56,879 - $84,458	-154 Reduced 0.65%	23,589 $11.6 Million
Q3 2022 Nov 14, 2022	BUY	$343.2 - $395.75 $1.18 Million - $1.36 Million	3,442 Added 16.95%	23,743 $8.38 Million
Q2 2022 Aug 12, 2022	BUY	$269.58 - $378.88 $831,923 - $1.17 Million	3,086 Added 17.93%	20,301 $7.69 Million
Q1 2022 May 16, 2022	SELL	$254.45 - $351.06 $332,057 - $458,133	-1,305 Reduced 7.05%	17,215 $5.43 Million
Q4 2021 Feb 11, 2022	BUY	$272.01 - $353.03 $2.47 Million - $3.21 Million	9,097 Added 96.54%	18,520 $6.49 Million
Q3 2021 Nov 12, 2021	BUY	$295.0 - $350.58 $248,685 - $295,538	843 Added 9.83%	9,423 $2.85 Million
Q1 2021 May 12, 2021	SELL	$268.3 - $380.31 $116,442 - $165,054	-434 Reduced 4.81%	8,580 $2.36 Million
Q4 2020 Feb 12, 2021	SELL	$248.13 - $308.36 $1.24 Million - $1.54 Million	-4,994 Reduced 35.65%	9,014 $2.65 Million
Q3 2020 Nov 12, 2020	BUY	$215.51 - $272.51 $290,076 - $366,798	1,346 Added 10.63%	14,008 $3.68 Million
Q2 2020 Aug 12, 2020	SELL	$127.44 - $232.72 $243,155 - $444,029	-1,908 Reduced 13.1%	12,662 $2.85 Million
Q1 2020 May 11, 2020	SELL	$108.83 - $165.23 $278,713 - $423,154	-2,561 Reduced 14.95%	14,570 $1.92 Million
Q4 2019 Feb 14, 2020	BUY	$106.59 - $164.21 $1.83 Million - $2.81 Million	17,131 New	17,131 $2.75 Million

Others Institutions Holding ARGX

# of Institutions

401

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $35.3B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Argenx Se Transaction History